Boxer Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-11,667
Closed -$7.48M – 41
2024
Q4
$7.48M Buy
+11,667
New +$7.29M 0.64% 34

Other funds holding JSPR

Boxer Capital Management's JSPR Position: Q1 2025 in Review

Boxer Capital Management sold out of Jasper Therapeutics (JSPR) in Q1 2025, closing a stake of 11,667 shares — an estimated $7.48M sold.

Boxer Capital Management first reported a position in JSPR in Q4 2024 and held it in 1 quarter. The position peaked at $7.48M in Q4 2024. 67 funds tracked by Wall St. Rank hold JSPR as of Q1 2025.

  • Boxer Capital Management reported no remaining Jasper Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Boxer Capital Management sold 11,667 Jasper Therapeutics shares in Q1 2025, an estimated $7.48M.
  • Boxer Capital Management first reported a position in Jasper Therapeutics in Q4 2024 and held it in 1 quarter.
  • Boxer Capital Management's Jasper Therapeutics position peaked at $7.48M in Q4 2024.
  • 67 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2025.

Based on Boxer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.